- What does ETAHX invest in?
- Under typical market conditions, this fund commits a substantial portion—at least 80%—of its total investable capital (net assets plus any borrowed funds for investment) to equity and equity-linked instruments. These holdings specifically target companies within the healthcare and life sciences sectors, encompassing a range of securities such as common shares, preferred stock, options, and convertible debt. Furthermore, the fund possesses the flexibility to acquire stakes in companies domiciled outside the United States, without any geographical restrictions. This can be done either directly or through American Depositary Receipts (ADRs). Its investment mandate also allows for the inclusion of companies across the entire spectrum of market capitalizations, from small-cap to large-cap firms.
- What is the expense ratio of ETAHX?
- Eventide Healthcare & Life Sciences A (ETAHX) charges an expense ratio of 1.56%. This is the annual fee deducted from fund assets to cover management and operations.
- How big is ETAHX?
- Eventide Healthcare & Life Sciences A (ETAHX) manages $1.79B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.
- Is ETAHX actively managed or an index fund?
- ETAHX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.
- When was ETAHX launched?
- Eventide Healthcare & Life Sciences A (ETAHX) launched in December 2012 and is managed by the fund issuer.
- How has ETAHX performed?
- ETAHX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.
